Advisory Board

Leo Notidis

Leo Notidis

Leonidas Notidis has spent nearly two decades advising Senior leadership teams from multinational corporations on entering global retail markets. As a previous Senior Director of Negotiation Strategy for a global leader in negotiation, he has consulted and coached C-suite leadership teams from over 200 of the Fortune 500 companies. His in-depth knowledge of the Retail and Pharmaceutical industry and the dynamics of the North American market have seen him take on the role of teacher, lecturer, consultant and practitioner. Having previously served on the Board of The Jenex Corporation, he is proud to lend his expertise from the pharmaceutical industry to once again build strategies to maximize the enormous potential present.

Joseph Galli

Joseph is involved in the early stage capital markets as an investor and sits on numerous Boards of Advisors in the healthcare & cannabis, technology and financial services industries. He is also the founding member of the Montreal chapter of the Private Capital Markets Association of Canada (PCMA) and is on the National Board of Directors for Canada. Over the past 35 years, Joseph has completed dozens of restructuring, due diligence and acquisition mandates in numerous industries on behalf of private equity and venture capital firms and industry clients. Joseph has directed over 200 conferences, seminars and workshops, has been a board member of several private and public organizations and is also an investor in a number of early stage public companies in Canada and the USA. Mr. Galli is the Chairman of PENTOR Finance, a residential mortgage lending company.
Stephen McNeill

Stephen McNeill

Stephen McNeill is a marketing strategist who has been helping businesses increase sales through innovative solutions. As managing partner of Q4 Communications, he has been instrumental in the evolution of Q4 from traditional marketing to digital advertising, sales funnels, chatbots and other emerging technologies that are having significant success in generating leads, and sales, for clients. He has been working in the cannabis industry for the past 5 years and is an associate of 3 West Management Group, an Ontario-based consulting firm of pharmaceutical, biomed and medical device experts with over 30 years experience in product launches, sales and marketing.

Michael Bosman

Michael is leveraging 20 years of senior commercial roles in the pharmaceutical/OTC industry to advise promising stakeholders in the medical device and cannabis industry. Michael’s breadth of experience includes multiple therapy areas at both Global and Affiliate operations at 3 major organizations- GlaxoWellcome, Eli Lilly, and, most recently, Novartis Pharma. Senior roles have included New Product Planning, Market Research, Marketing, Sales, Brand Planning and extensive collaboration with Clinical, Health Policy & Regulation divisions. Michael has been an active team leader during all phases of product development from 6 years pre-launch through launch through to generic introduction. Michael has also served as a Global Expert Consultant on Customer Segmentation and Direct-To-Consumer marketing.

Steven Prescott Bennett

Steven Prescott Bennett, PH.D.

Dr. Steven Bennett has over 20 years of research experience in multiple central nervous system (“CNS”) disorders, pain, and cancer. Dr. Bennett has developed expertise in molecular biology, cell biology, animal models, project leadership and research strategy. Dr. Bennett, a bench-to-clinic researcher, has trained at top academic institutes with reputed leaders in the field of Alzheimer’s disease, opiate receptors and melanoma.

Over the past 5 years, Dr. Bennett has shifted towards the cannabis industry and cannabis research. The development of an effective transdermal cannabinoid patch in 2014 lead to the launch of Prescott Logic, LLC., a private research laboratory owned by Dr. Bennett. Dr. Bennett became the Scientific Director of Evolab in Denver, Colorado, focusing on cannabis processing, namely extraction, distillation, and preparative chromatography of the plant. At Evolab total revenues climbed over 10 times during Dr. Bennett’s tenure. In 2017 Dr. Bennett joined the Maricann Group out of Toronto as Chief Scientific Officer to further the processing capacity and continue the development of medical cannabis products. Recently, Dr. Bennett incorporated Prescott Logic Technologies, Ltd. in British Columbia and soon to incorporate in Germany. Dr. Bennett will focus on product, equipment, and scientific research and development in order to advance of scientific knowledge of cannabis and cannabinoid/terpene based therapies.

Dr. Bennett‘s role with Therma Bright will be to focus on the development of advanced pain relief formulations to be incorporated with Therma Bright’s thermal therapy technology and advise on how best to test Therma Bright‘s thermal technology with cannabinoids and to advise on optimal research protocols and methodologies for Therma Bright’s technology platform.

Gilbert Sharpe

Gilbert Sharpe

Is the former long-time Director of the Legal Branch of the Ontario Ministry of Health and Long-Term Care, brings invaluable experience from a distinguished 40-year career in legal practice and advisory roles. He recently established his own boutique healthcare advisory service, following 15 years in private practice as a partner at several major Bay Street law firms.

Gilbert offers unparalleled experience in healthcare public policy and regulation, and intimately understands the complex realm of evolving public and private healthcare in Canada. Through his involvement with the Ministry of Health since 1975, and associated work with numerous government ministries and agencies, Gilbert has influenced some of the most important legal issues and policy matters affecting modern health care in Canada. This includes the development of legislation and policies to improve the Ontario and Canadian health care system.

Internationally, Gilbert has been an advisor on healthcare projects for the World Bank, Inter-American Bank, and the World Health Organization. He advised on US healthcare reforms in part during his tenure as a professor in the health law group at Loyola University in Chicago.

Gilbert holds several professorships, including the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. Gilbert received his LLB and LLM from Osgoode Hall Law School. He is President of the Canadian Institute of Law and Medicine and Editor-in-Chief of Health Law in Canada. Gilbert has published several books, hundreds of articles, and is a sought-after speaker at conferences.

Gilbert Sharpe brings to Therma Bright years of experience in health law and government policy. Mr. Sharpe’s healthcare experience encompasses both academia and practical medicine. He has introduced medical devices from around the world to the International & Canadian Medical community and has been a catalyst to bring them to market.

Bruno Maruzzo

Bruno Maruzzo

Bruno Maruzzo has over 25 years’ experience in working with small to medium size technology companies in the computer, electronics and medical device fields as well as working in venture capital investing in technology-oriented companies. Through his consulting company, TechnoVenture Inc., he has provided general management, financing, business development and technical services to a variety of publicly traded and private technology and medical companies.

Mr. Maruzzo has served as senior management, director and advisor to a number of publicly traded medical technology companies.

Mr. Maruzzo holds a BASc in Electrical Engineering from the University of Waterloo, a MASC in Biomedical Engineering from the University of Toronto and an MBA from the University of Toronto.